Mark D. Moore
Impact in
-
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cancer Research top 10%
Papers in
-
- Pulmonary Hypertension Research and Treatments 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- MicroRNA in disease regulation 2
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Mark W. Geraci (14 shared papers)Norbert F. Voelkel (8 shared papers)Rubin M. Tuder (5 shared papers)Heiko Golpon (5 shared papers)Bifeng Gao (3 shared papers)Sylk Sotto‐Santiago (7 shared papers)Christopher D. Coldren (4 shared papers)Robert L. Keith (4 shared papers)
- Journals
- CHEST Journal (5 papers)American Journal of Respiratory Cell and Molecular Biology (3 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)Toxicology and Applied Pharmacology (1 paper)Gene (1 paper)
- Partner nations
- United StatesSouth KoreaPuerto Rico
In The Last Decade
Mark D. Moore
22 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Pulmonary and Respiratory Medicine 696
- Cancer Research 185
- Biochemistry 80
- Cardiology and Cardiovascular Medicine 212
- Pharmacology 135
Countries citing papers authored by Mark D. Moore
This map shows the geographic impact of Mark D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Moore more than expected).
Fields of papers citing papers by Mark D. Moore
This network shows the impact of papers produced by Mark D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Moore. The network helps show where Mark D. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 220 | |
| 2 | 1999 | 166 | |
| 3 | 2004 | 120 | |
| 4 | Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. | 2002 | 117 |
| 5 | 2004 | 112 | |
| 6 | 2007 | 107 | |
| 7 | 2001 | 85 | |
| 8 | 2003 | 74 | |
| 9 | 1988 | 44 | |
| 10 | 1991 | 35 | |
| 11 | 2006 | 31 | |
| 12 | 2008 | 25 | |
| 13 | 1991 | 16 | |
| 14 | 2004 | 13 | |
| 15 | Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line. | 1998 | 12 |
| 16 | 1998 | 9 | |
| 17 | 1997 | 7 | |
| 18 | 1997 | 6 | |
| 19 | 1976 | 6 | |
| 20 | 2005 | 4 |
About Mark D. Moore
Mark D. Moore is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Pharmacology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Peptidase Inhibition and Analysis (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), RNA modifications and cancer (3 papers), MicroRNA in disease regulation (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (696 citations), Cancer Research (185 citations), Biochemistry (80 citations), Cardiology and Cardiovascular Medicine (212 citations) and Pharmacology (135 citations). Mark D. Moore has collaborated with scholars based in United States, South Korea and Puerto Rico. Frequent co-authors include Mark W. Geraci, Norbert F. Voelkel, Rubin M. Tuder, Heiko Golpon, Bifeng Gao, Sylk Sotto‐Santiago, Christopher D. Coldren, Robert L. Keith, S. Patrick Nana‐Sinkam and Michael E. Yeager. Their work appears in journals such as CHEST Journal, American Journal of Respiratory Cell and Molecular Biology, American Journal of Respiratory and Critical Care Medicine, Toxicology and Applied Pharmacology and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.